A phase I/IIa trial of atorvastatin in Japanese patients with acute Kawasaki disease and coronary artery aneurysms
{{output}}
Background: In the United States, a phase I/IIa dose-escalation study of atorvastatin in Kawasaki disease (KD) patients with coronary artery aneurysms (CAAs) demonstrated the safety and pharmacokinetics (PK) of atorvastatin. Howe... ...
